TrialThe New England journal of medicine2019
Phase 1 Trial of an RNA Interference Therapy for Acute Intermittent Porphyria.
Eliane Sardh et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
131 papers cite itlatest 60 shown
this paperpooled ittrialcites it